Blood Markers in Ewing Sarcoma Patients
Studies blood samples from patients with Ewing sarcoma to look for biological markers.
Plain-language title generated from the registry record
Registry title: Identification of Circulating Biomarkers Associated With Extracellular Vesicles in Sarcomas
Key facts
- Where
- Bologna, ItalySee the site
Where in Italy
- Istituto ortopedico Rizzoli Laboratorio di Ricerc Oncologica e Genomica funzioanleBologna, ItalyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Istituto Ortopedico Rizzoli
- Trial code
- NCT07685405
- Record updated
- 6 July 2026
- Original description
The study involves blood samples from patients with Ewing's sarcoma to identify circulating biomarkers as a tool for the preclinical validation of innovative therapeutic approachesRead full original descriptionShow less
Feasibility Study for the Identification of Circulating Biomarkers Associated With Extracellular Vesicles in Sarcomas
The study involves blood samples from patients with Ewing's sarcoma to identify circulating biomarkers as a tool for the preclinical validation of innovative therapeutic approaches
Inclusion: Male and female patients of any age diagnosed with Ewing sarcoma; Signed, study-specific informed consent form for the BIOVES study (cancer patients); Male and female patients of legal age without a cancer diagnosis; Signed, study-specific informed consent form for the BIOVES study (non-cancer patients).
Exclusion: Patients who do not meet all inclusion criteria; -.